The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight.
🤖 AI summary not generated yet
Click the button below to generate a one-time AI review summary from public sources.